ENAGenomicsFox Chase Cancer Centerhttps://www.ebi.ac.uk/ena/browser/view/PRJNA846616(1): RNA-seq results of ALCL cell lines (MAC1, MAC2A, Karpas299, TLBR1, and TLBR2) transduced with CTRL, IL-1a or MYD88 sgRNAs. (2): RNA-seq results of ALCL cell lines (MAC1 and Karpas299) treated with the IRAK4 inhibitor AS2444697 or Anakinra.ENAfalseThe upregulated IL-1R pathway mediates immunoregulatory responses and immunotherapy efficiency in Anaplastic Large Cell Lymphoma2023-08-012023-08-01PRJNA846616